{"entity":{"id":"paper-vincent-bioessays","kind":"paper","name":"Cancer: a de-repression of a default survival program common to all cells?: a life-history perspective on the nature of cancer","aka":[],"tldr":"Paper cited by one term page, indexed on Europe PMC as PubMed record 22105565 and published in BioEssays; the citing page links this DOI, which is how the record was matched.","summary":"Cancer viewed as a programmed, evolutionarily conserved life-form, rather than just a random series of disease-causing mutations, answers the rarely asked question of what the cancer cell is for, provides meaning for its otherwise mysterious suite of attributes, and encourages a different type of thinking about treatment. The broad but consistent spectrum of traits, well-recognized in all aggressive cancers, group naturally into three categories: taxonomy (\"phylogenation\"), atavism (\"re-primitivization\") and robustness (\"adaptive resilience\"). The parsimonious explanation is not convergent evolution, but the release of an highly conserved survival program, honed by the exigencies of the Pre-Cambrian, to which the cancer cell seems better adapted; and which is recreated within, and at great cost to, its host. Central to this program is the Warburg Effect, whose malign influence permeates well beyond aerobic glycolysis to include biomass interconversion and genomic heuristics. Warburg-type metabolism and genomic instability are targets whose therapeutic disablement is a major priority.\n\nIndexed on Europe PMC as PubMed record 22105565 (DOI 10.1002/bies.201100049). Matched by DOI alone: one term page cites this DOI among its external links (the pages are listed under Related), and this page was written so that the citation resolves inside OnCo. No figure has been checked by an editor.","asOf":"2026-09-22","links":[{"label":"Bioessays 2012","url":"https://doi.org/10.1002/bies.201100049"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/22105565/"},{"label":"Europe PMC","url":"https://europepmc.org/article/MED/22105565"}],"tags":["europepmc-ingest"],"related":["atavistic-theory-of-cancer"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"BioEssays","year":2012,"doi":"10.1002/bies.201100049","pmid":"22105565","authors":"Vincent M","paperType":"observational","findings":[],"whatItMeans":"One term page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.","caveats":["Matched to the citing OnCo records by DOI alone; the summary reproduces the Europe PMC abstract and no figure has been verified against the full paper."]},"route":"/key-papers/paper-vincent-bioessays/","neighbours":{"term":[{"id":"atavistic-theory-of-cancer","kind":"term","name":"Atavistic theory: cancer as a reversion to an ancient programme","route":"/terms/atavistic-theory-of-cancer/"}]}}